A Real-World Study to Evaluate the Clinical Performance and Safety of da Vinci SP Surgical System for Single-Port Colorectal Surgeries(SPiM-RWS-CR)
Completed
- Conditions
- Single-Port Colorectal Surgeries
- Interventions
- Procedure: procedure
- Registration Number
- NCT06141421
- Lead Sponsor
- Ruijin Hospital
- Brief Summary
A real-world study to evaluate the clinical performance and safety of da Vinci SP Surgical System ("SP single-port robot" for short) for single-port robot-assisted colorectal surgeries in the real world, providing a real world evidence for clinical application of the product in the Chinese population.
English name: da Vinci SP Surgical System Model and specification: SP1098 Manufacturer: Intuitive Surgical, Inc.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
- Subjects who have received or plan to receive colorectal surgeries with the SP single-port robot, such as low anterior resection of the rectum with or without total mesorectal excision; right hemicolectomy, left hemicolectomy and sigmoidectomy with or without transanal total mesocolic excision and central blood vessel ligation; and transanal minimally invasive surgery.
- Patients who voluntarily decide to participate in the study and sign the ICF (or exempt from signature of the ICF as approved by the EC).
Exclusion Criteria
- Patients with missing data on the primary endpoint in retrospective cases;
- Subjects having any contraindications of single-port robot surgery;
- The intraoperative anatomy determined that minimally invasive surgery was not suitable;
- Patients who are considered inappropriate to participate in this study by investigator.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description RWS study for SP CR Surgeries da Vinci SP Surgical System(SP1098) procedure -
- Primary Outcome Measures
Name Time Method Intraoperative conversion rate Intraoperative The incidence of device-related or likely related complications of Clavien-Dindo classification grade III or higher at postoperative 30 days 30 days
- Secondary Outcome Measures
Name Time Method Postoperative pain score follow-ups 1 day (24±4 h), 3 days (72±4 h) and 1 month (30±5 days) after the surgery. Admission to ICU and ICU LOS During the follow-up 1 day before discharge Urethral catheter indwelling duration in the follow-up 1 month after the surgery Surgical duration Intraoperative Length of stay (LOS) During the follow-up 1 day before discharge Intraoperative bleeding volume Intraoperative The rate of intraoperative blood transfusion Intraoperative Short-term recovery of functions in the follow-up 1 month after the surgery
Trial Locations
- Locations (1)
Ruijin Hospital
🇨🇳Shanghai, Shanghai, China